Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 34

Page
per page
  1. BLU9931
    A8706 BLU9931
    Target: FGFR
    Summary: FGFR4 inhibitor,potent and irreversible
      ≥50.9 mg/mL
  2. PX 12
    A4509 PX 12
    Target: Trx
    Summary: Trx-1 inhibitor
      insoluble in H2O; ≥8.75 mg/mL
  3. CA-074 Me
    A8239 CA-074 Me
     7 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      insoluble in H2O; ≥19.88 mg/mL
  4. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  5. PD168393
    A2024 PD168393
    Target: PDGFR|FGFR|EGFR|PKC|insulin
    Summary: EGFR inhibitor
  6. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    Target: ErbB
    Summary: HER inhibitor
      ≥23.5 mg/mL
  7. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     1 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL
  8. Z-IETD-FMK
    B3232 Z-IETD-FMK
     12 Citation
    Target: Caspases
    Summary: Caspase-8 inhibitor
      ≥32.73 mg/mL
  9. Z-LEHD-FMK
    B3233 Z-LEHD-FMK
     8 Citation
    Target: Caspases
    Summary: Irreversible Caspase-9 inhibitor.
      insoluble in H2O; ≥107.4 mg/mL
  10. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: inhibitor of Ubiquitin-Activating Enzyme (E1)

Items 1-10 of 34

Page
per page